Is HairGenesis® available in the GCC?

HairGenesis® has been distributed across the GCC for over 25 years through Boots Middle East, Aster Pharmacy, Life Pharmacy, and Bin Sina Pharmacy. Current licensing and territorial availability is handled through Continuum Innovative directly.

What is the mechanism of TrichoCyte®?

TrichoCyte® combines botanical 5α-reductase inhibitors with a β-cyclodextrin delivery vector. It selectively inhibits pathological DHT synthesis at the follicular level while sparing systemic androgen pathways — a differentiated approach from finasteride and minoxidil.

Who developed HairGenesis® and TrichoCyte®?

Both were developed by Dr. Geno Marcovici, PhD, DABAAHP, founder of Continuum Innovative, over three decades of peer-reviewed research in hair follicle biology and androgen signaling.

How does HairGenesis® differ from minoxidil or finasteride?

HairGenesis® is a botanically-derived, nano-enabled system with an oral and topical component. Unlike finasteride, it does not act as a systemic androgen suppressor. Unlike minoxidil, it addresses the underlying DHT pathway rather than acting purely as a vasodilator.

Continuum

Innovative

Life Sciences Division

TrichoCyte™ · Brand Program

Enhanced Drug Delivery ofNatural Hair-Stimulating Compounds.

Q: Is TrichoCyte® used in clinical practice?

Yes. TrichoCyte® is deployed clinically in the United States by Prestige Medical Group (Tustin & Santa Ana, California) as the botanical foundation of their CryoTouch™ MD with TrichoCyte® SML non-surgical hair restoration protocol — combining nano-encapsulated botanical actives with topical carboxy delivery to improve scalp microcirculation.

A proprietary formulation pairing naturally-based 5α-reductase inhibitors and anti-inflammatory phytochemicals with a β-cyclodextrin drug-delivery vector — the first reported use of naturally-based delivery agonists in amplifying the clinical benefit of botanically-based hair-growth formulations.

"My hair was thinning, but now it's thick almost like it was when I was younger. I'm totally sold on TrichoCyte."

Veronica L. · Cherry Hill, NJ

Longitudinal Clinical Photography

270 days. Two subjects. Documented regrowth.

Vertex-scalp photography captured at Day 0, Day 90, Day 180, and Day 270 of the cyclodextrin inclusion-complex protocol. At baseline, significant baldness was observed in both subjects. By Day 270, scalp hair loss was no longer evident in either client.

Study Subject #1

Study Subject #1 — Day 180 — Treatment
Day 180

Study Subject #1 — Day 270 — Treatment
Day 270

Study Subject #2

Study Subject #2 — Day 180 — Treatment
Day 180

Study Subject #2 — Day 270 — Treatment
Day 270

Mechanism of Action

A botanically-derived formula, invaginated in β-cyclodextrin.

In a landmark peer-reviewed study, Geno Marcovici, PhD, DABAAHP and Alan Bauman, MD demonstrated an amplified clinical outcome for a proprietary formulation incorporating naturally-based anti-inflammatory compounds and highly potent 5α-reductase inhibitors. The study described the enhanced outcome resulting via the successful invagination of the active formula in a highly efficient drug-delivery vector molecule — β-cyclodextrin. This study appears to report the first use of naturally-based drug-delivery vectors as agonists in amplifying the clinical benefit of botanically-based hair-growth formulations.

β-Cyclodextrin (β-CD)

A cone-shaped cyclic, nontoxic oligosaccharide of seven glucose units joined as α-(1→4) isomers. Hydrophilic at the outer surface and hydrophobic in the cavity at its center — β-CD forms a stable, insoluble inclusion complex with naturally-based actives including β-sitosterol. Because β-CD is itself water-soluble, hydrophobic guest molecules can be encapsulated in its non-polar cavity, then released for controlled, targeted delivery.

β-Cyclodextrin molecular diagram with botanical active encapsulated in central cavity — Inclusion-complex schematic

The TrichoCyte™ System

Topical, oral, and cosmetic forms — designed to work together.

In Their Own Words

From the people using it.

"My hair was thinning, but now it's thick almost like it was when I was younger. I'm totally sold on TrichoCyte."
Veronica L. · Cherry Hill, NJ

"My hairstylist said ‘what have you been doing, your hair is so much thicker.’"
Alex M. · New York, NY

"Can't say enough about how impressed I am by this new product. It's better than any hair drug I tried, for sure. And I love that it's safe and natural."
Tony B. · Franklin Lakes, NJ

20+ Years of Peer-Reviewed Research

Functional hypothesis supported by published medical science.

An Uncontrolled Case Series Using a Botanically Derived, β-Cyclodextrin Inclusion Complex in Two Androgenetic Alopecia-Affected Male Subjects

Geno Marcovici, PhD, DABAAHP · Alan Bauman, MD

Published 10 August 2020

A landmark peer-reviewed study demonstrating an amplified clinical outcome for a proprietary formulation incorporating naturally-based anti-inflammatory compounds and highly potent 5α-reductase inhibitors invaginated within β-cyclodextrin — the first reported use of naturally-based drug-delivery vectors as agonists in amplifying the clinical benefit of botanically-based hair-growth formulations.

hair loss · advanced drug delivery · nanoparticles · natural hair loss treatment · phytochemicals · β-cyclodextrin

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5α-reductase in the treatment of androgenetic alopecia

Nelson Prager · Karen Bickett · Nita French · Geno Marcovici

J Altern Complement Med · PMID 12006122 · DOI 10.1089/acm.2002.8.143

First placebo-controlled, double-blind trial of botanically derived 5α-reductase inhibitors (liposterolic extract of Serenoa repens and beta-sitosterol) in AGA. 60% of subjects on active formulation rated as improved at final visit. Established the effectiveness of naturally-occurring 5AR inhibitors against AGA for the first time.

Inhibition of inflammatory gene expression in keratinocytes using a composition containing Carnitine, Thioctic Acid & LSESr

Sridar Chittur · Brian Parr · Geno Marcovici

PMID 19692448 · PMCID PMC3137880 · DOI 10.1093/ecam/nep102

In a well-validated keratinocyte assay, the LSESr + carnitine + thioctic-acid composition effectively suppressed LPS-activated gene expression of chemokines (CCL17, CXCL6, LTB4) associated with inflammation and apoptosis — supporting a two-pronged 5AR + anti-inflammatory approach to AGA.

Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays

Li Chen · Jiaolong Wang · Glen Mouser · Yan Chun Li · Geno Marcovici

PMID 26990224 · DOI 10.1002/ptr.5611

In vitro assays of hair-follicle dermal papilla and LNCaP prostate cell lines: the novel composition down-regulated disease-characteristic mRNA expression and outperformed finasteride — proof of concept for simultaneously targeting 5AR and inflammatory mediators in AGA and BPH.

For Authorized Commercialization Partners

On the cutting edge of technology in the field.

The TrichoCyte™ brand is built for clinical practices that demand peer-reviewed substantiation, tailored ranges, and uncompromising quality control.

Ongoing R&D

Latest developments arising from research at our own facilities and from collaborative partners at the University of Chicago, SUNY New York, and elsewhere — backed by numerous peer-reviewed publications.

Full Marketing Materials

Tailored marketing tools and support designed to fit each clinical practice — ensuring the TrichoCyte™ brand performs in your specific channel.

Dedicated Senior Contact

Direct relationship with a dedicated, personalized contact — experts and decision-makers who can help grow the business the TrichoCyte™ brand represents.

Multi-Channel Expertise

Established success across pharmacies, the grocery sector, hospitals, governments, and healthcare tenders — manufacturing only the highest quality healthcare products.

Tailored Product Range

Not every haircare product fits every practice. We take the time to understand your needs and tailor the range to your client base.

cGMP / Quality Control

All TrichoCyte™ formulations are manufactured under tight cGMP standards with state-of-the-art QC/QA. Routine self-evaluations and critical batch numbering on every SKU and LOT.

From a TrichoCyte® User

Results are excellent so far. My hair was thinning, but now it’s thick almost like it was when I was younger. I’m totally sold on TrichoCyte.

Ned A.· Hollywood, FL

Distribution Inquiries

Bring TrichoCyte™ to your practice or territory.

For distribution opportunities, pricing, and ordering, contact us directly. We work with pharmacies, clinical practices, hospitals, the grocery sector, governments, and healthcare tenders worldwide.

Clinical Adoption

TrichoCyte® in clinical practice

TrichoCyte® is deployed clinically in the United States by Prestige Medical Group (Tustin & Santa Ana, California) as the botanical foundation of their CryoTouch™ MD with TrichoCyte® SML non-surgical hair restoration protocol. The protocol pairs TrichoCyte®'s nano-encapsulated botanical actives with topical carboxy delivery (TCD) to improve scalp microcirculation and enhance follicular bioavailability.

Real-world clinical use validates the platform thesis: a plant-based hair growth protocol delivering active compounds directly to the follicle, without injections, surgery, or systemic androgen suppression.

View the Prestige Medical Group protocol